spinal muscular atrophy treatments

Spinal muscular atrophy stakeholders rolled up their sleeves and dug into the status of therapy development at a National Institutes of Health meeting

posted on November 4, 2010 - 9:58am
In a sign of the significant progress being made in spinal muscular atrophy (SMA) research, the National Institutes of Health (NIH) convened a meeting in October that examined the status of laboratory research, clinical trials and strategies for drug development in this disease, with an eye toward speeding the process.

New content is being added every day. Please check back again.